Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    15803162 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting The Impact of Caffeine on Cognition in Schizophrenia
Conditions: Schizophrenia;   Caffeine
Interventions: Drug: Caffeine;   Drug: Placebo
2 Completed
Has Results
Treatment Study for Cognitive Deficits in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: MK-0777;   Drug: placebo
3 Completed
Has Results
Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 Study
Condition: Schizophrenia
Interventions: Drug: Merck L-830982;   Drug: Placebo

Indicates status has not been verified in more than two years